Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Tanya Perez

Physician Assistant San Antonio, TX Physician Assistant

NPI 1841596400 CMS profile 10962346

303 N Frio St, Ste 102, San Antonio, TX 78207

Open in the dashboard

General payments

$9,140

262 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tanya Perez of San Antonio, TX is reported in the CMS Open Payments database as having received $9,140 across 262 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,202 56
2024 General $1,728 45
2023 General $2,046 59
2022 General $1,867 57
2021 General $1,297 45

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tanya Perez
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Tanya Perez were reported at $2,202. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Tanya Perez Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,297 $132 $37–$438 $132
2022 $1,867 $155 $48–$522 $149
2023 $2,046 $167 $52–$557 $160
2024 $1,728 $178 $55–$600 $164
2025 $2,202 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. ViiV Healthcare Company $3,822 119 payments
  2. Gilead Sciences, Inc. $2,103 62 payments
  3. AbbVie, Inc. $545 15 payments
  4. Theratechnologies Inc. $458 12 payments
  5. Axsome Therapeutics, Inc. $371 3 payments
  6. EMD Serono, Inc. $360 11 payments
  7. Janssen Products, LP $235 2 payments
  8. Janssen Biotech, Inc. $192 11 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $191 6 payments
  10. Napo Pharmaceuticals Inc $130 3 payments
  11. Other $733 18 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $9,140 262 payments
Products named General payments · program years 2021–2025
  1. DOVATO $1,961 74 payments
  2. CABENUVA $666 18 payments
  3. APRETUDE $554 14 payments
  4. SYMTUZA $543 14 payments
  5. MAVYRET $516 14 payments
  6. TROGARZO $422 11 payments
  7. Auvelity $371 3 payments
  8. EGRIFTA $324 11 payments
  9. NURTEC ODT $313 7 payments
  10. Biktarvy $281 4 payments
  11. Other $1,461 44 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 27 drugs

Part D claims

599

Median for Physician Assistant: 241

Drug cost

$1,031,670

Median for Physician Assistant: $4,110

Branded share of claims

60.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Biktarvy Bictegrav/Emtricit/Tenofov Ala Brand 90 $357,080
Dovato Dolutegravir Sodium/Lamivudine Brand 75 $214,353
Rukobia Fostemsavir Tromethamine Brand 13 $117,725
Cabenuva Cabotegravir/Rilpivirine Brand 12 $84,929
Prezcobix Darunavir/Cobicistat Brand 27 $64,639
Descovy Emtricitabine/Tenofov Alafenam Brand 27 $56,506
Tivicay Dolutegravir Sodium Brand 22 $46,224
Juluca Dolutegravir/Rilpivirine Brand 13 $44,722
Isentress Hd Raltegravir Potassium Brand 11 $20,647
Edurant Rilpivirine Hcl Brand 12 $15,521

The 10 drugs with the highest cost, of 27 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 2 billing codes

Paid by Medicare

$1,982

Medicare's payments for the services billed

Medicare patients

23

Average age 77

Services billed

27

12 women, 11 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 61%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 12 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DOVATO
  • ViiV Healthcare Company $343
$343 75 —
CABENUVA
  • ViiV Healthcare Company $297
$297 12 —
MAVYRET
  • AbbVie, Inc. $182
$182 — —
APRETUDE
  • ViiV Healthcare Company $163
$163 — —
Biktarvy
  • Gilead Sciences, Inc. $122
$122 90 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 12 in the dashboard with a free account

Records

262 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record